Brittany J. Poelaert

Closest collaborators

The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Joyce C. Solheim · 4 shared papers, 2018–2022 · strength 0.44
   • Paper The histone deacetylase inhibitor M344 as a multifaceted therapy for pancreatic cancer. DOI 10.1371/journal.pone.0273518↗
   • Paper Beta 2-microglobulin regulates amyloid precursor-like protein 2 expression and the migration of pancreatic cancer cells. DOI 10.1080/15384047.2019.1580414↗
   • Paper Amyloid Precursor-like Protein 2 Expression Increases during Pancreatic Cancer Development and Shortens the Survival of… DOI 10.3390/cancers13071535↗
2. Bailee H. Sliker · 2 shared papers, 2019–2022 · strength 0.26
   • Paper The histone deacetylase inhibitor M344 as a multifaceted therapy for pancreatic cancer. DOI 10.1371/journal.pone.0273518↗
   • Paper Beta 2-microglobulin regulates amyloid precursor-like protein 2 expression and the migration of pancreatic cancer cells. DOI 10.1080/15384047.2019.1580414↗
3. Shelby M. Knoche · 2 shared papers, 2021–2022 · strength 0.26
   • Paper The histone deacetylase inhibitor M344 as a multifaceted therapy for pancreatic cancer. DOI 10.1371/journal.pone.0273518↗
   • Paper Amyloid Precursor-like Protein 2 Expression Increases during Pancreatic Cancer Development and Shortens the Survival of… DOI 10.3390/cancers13071535↗
4. Alaina C. Larson · 2 shared papers, 2021–2022 · strength 0.26
   • Paper The histone deacetylase inhibitor M344 as a multifaceted therapy for pancreatic cancer. DOI 10.1371/journal.pone.0273518↗
   • Paper Amyloid Precursor-like Protein 2 Expression Increases during Pancreatic Cancer Development and Shortens the Survival of… DOI 10.3390/cancers13071535↗
5. Surinder K. Batra · 2 shared papers, 2018–2021 · strength 0.19
   • Paper Amyloid Precursor-like Protein 2 Expression Increases during Pancreatic Cancer Development and Shortens the Survival of… DOI 10.3390/cancers13071535↗
   • Paper Emerging trends in the immunotherapy of pancreatic cancer. DOI 10.1016/j.canlet.2017.12.012↗
6. Jennifer D. Black · 1 shared paper, 2022 · strength 0.15
   • Paper The histone deacetylase inhibitor M344 as a multifaceted therapy for pancreatic cancer. DOI 10.1371/journal.pone.0273518↗
7. Madeline T. Olson · 1 shared paper, 2022 · strength 0.15
   • Paper The histone deacetylase inhibitor M344 as a multifaceted therapy for pancreatic cancer. DOI 10.1371/journal.pone.0273518↗
8. Ying Yan · 1 shared paper, 2022 · strength 0.15
   • Paper The histone deacetylase inhibitor M344 as a multifaceted therapy for pancreatic cancer. DOI 10.1371/journal.pone.0273518↗
9. Haley L. Peters · 1 shared paper, 2019 · strength 0.11
   • Paper Beta 2-microglobulin regulates amyloid precursor-like protein 2 expression and the migration of pancreatic cancer cells. DOI 10.1080/15384047.2019.1580414↗
10. Poomy Pandey · 1 shared paper, 2021 · strength 0.11
    • Paper Amyloid Precursor-like Protein 2 Expression Increases during Pancreatic Cancer Development and Shortens the Survival of… DOI 10.3390/cancers13071535↗
11. H. Carlo Maurer · 1 shared paper, 2021 · strength 0.11
    • Paper Amyloid Precursor-like Protein 2 Expression Increases during Pancreatic Cancer Development and Shortens the Survival of… DOI 10.3390/cancers13071535↗
12. Parthasarathy Seshacharyulu · 1 shared paper, 2021 · strength 0.11
    • Paper Amyloid Precursor-like Protein 2 Expression Increases during Pancreatic Cancer Development and Shortens the Survival of… DOI 10.3390/cancers13071535↗
13. Kenneth P. Olive · 1 shared paper, 2021 · strength 0.11
    • Paper Amyloid Precursor-like Protein 2 Expression Increases during Pancreatic Cancer Development and Shortens the Survival of… DOI 10.3390/cancers13071535↗
14. Satyanarayana Rachagani · 1 shared paper, 2021 · strength 0.11
    • Paper Amyloid Precursor-like Protein 2 Expression Increases during Pancreatic Cancer Development and Shortens the Survival of… DOI 10.3390/cancers13071535↗
15. Balaji Narasimhan · 1 shared paper, 2018 · strength 0.07
    • Paper Emerging trends in the immunotherapy of pancreatic cancer. DOI 10.1016/j.canlet.2017.12.012↗
16. Kasturi Banerjee · 1 shared paper, 2018 · strength 0.07
    • Paper Emerging trends in the immunotherapy of pancreatic cancer. DOI 10.1016/j.canlet.2017.12.012↗
17. Shailendra Kumar Gautam · 1 shared paper, 2018 · strength 0.07
    • Paper Emerging trends in the immunotherapy of pancreatic cancer. DOI 10.1016/j.canlet.2017.12.012↗
18. Rakesh Bhatia · 1 shared paper, 2018 · strength 0.07
    • Paper Emerging trends in the immunotherapy of pancreatic cancer. DOI 10.1016/j.canlet.2017.12.012↗
19. Maneesh Jain · 1 shared paper, 2018 · strength 0.07
    • Paper Emerging trends in the immunotherapy of pancreatic cancer. DOI 10.1016/j.canlet.2017.12.012↗
20. Sushil Kumar K · 1 shared paper, 2018 · strength 0.07
    • Paper Emerging trends in the immunotherapy of pancreatic cancer. DOI 10.1016/j.canlet.2017.12.012↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.